Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
509 Leser
Artikel bewerten:
(2)

Quest Diagnostics: Ruth Clements Speaks at National Action Network Event Addressing Health Inequities

NORTHAMPTON, MA / ACCESSWIRE / May 21, 2024 / Quest Diagnostics East Region President Ruth Clements explained how routine diagnostic testing is crucial to closing gaps in healthcare as part of health panel at the National Action Network (NAN) Convention in April.

Hosted by Choose Healthy Life (CHL), Ruth joined "The State of Black Health: Building a New Normal," to discuss the gap in care for the black community. The panel was moderated by Choose Healthy Life founder Debra Frazer-Howze and included NYC Commissioner of Health Dr. Ashwin Vasan, Rev. Dr. Que English, Dr. Fatima Cody Stanford (Harvard Medical School), and others.

In her previous role as Vice President/General Manager of Infectious Diseases & Immunology (IDI) at Quest, Ruth was instrumental in the COVID-19 response planning for Quest Diagnostics. She explained that the disproportionate impact of COVID-19 in black communities in 2020 finally shined a light on existing inequities in health outcomes.

"For me, being in charge of the COVID response for Quest, which was a hectic time, I could not ignore the facts," said Ruth. "The facts that people who looked like me were dying unnecessarily because they didn't have access to testing, they didn't have the right information, and they didn't have doctors that looked like them that they could trust. Misinformation in the community around COVID that killed people was just heartbreaking to me."

Quest launched Quest for Health Equity (Q4HE) in 2020 during the heart of the pandemic response. Quest made a commitment to do its part to address the systemic inequity fueling the health equity gap and work towards meaningful progress by working with dedicated partners like Choose Healthy Life.

The Q4HE team continues to work toward removing the barriers deepening health inequities in under-resourced communities and improve equity in testing and screening, which includes Blueprint for Wellness®.

Blueprint for Wellness is Quest's comprehensive biometric screening that measures more than 25 key indicators of health, including blood glucose, cholesterol and hemoglobin A1C.

"We are connecting people to care," said Ruth. "For us, it is about people knowing their health risks as well as their health strengths and taking action and following that up with care."

In 2023, Q4HE provided 6,113 no-cost Blueprint for Wellness tests in marginalized communities.

"It is a privilege as Quest to be a part of this initiative," said Ruth. "Healthcare is a team sport- we have to do this together."

???View additional multimedia and more ESG storytelling from Quest Diagnostics on 3blmedia.com.

Contact Info:
Spokesperson: Quest Diagnostics
Website: https://www.3blmedia.com/profiles/quest-diagnostics
Email: info@3blmedia.com

SOURCE: Quest Diagnostics



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.